[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608347":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":32,"responsibleParty":195,"collaborators":10,"id":197,"slug":10,"hasResults":198,"nctId":199,"briefTitle":200,"officialTitle":201,"acronym":202,"eligibilityCriteria":203,"healthyVolunteers":198,"sex":204,"minAge":205,"maxAge":10,"enrollmentInfo":206,"targetDuration":10,"studyType":209,"phases":10,"briefSummary":210,"conditions":211,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":213,"lastUpdatePostDateStruct":214,"startDateStruct":217,"completionDateStruct":219,"leadSponsor":221,"locationsCount":222},{"fullName":5,"class":6},"Hoffmann-La Roche","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Glofitamab treatment",null,"Participants will be enrolled into the study either prior to initiation of glofitamab therapy or within 90 days of starting glofitamab therapy.",[13],"Drug: Glofitamab",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DRUG","Glofitamab","Participants will receive glofitamab as part of a cancer-treatment regimen in a real-world setting. No intervention will be administered by study investigators.",[9],[21],{"name":22,"affiliation":5,"role":23},"Clinical Trials","STUDY_DIRECTOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Reference Study ID Number: ML45172 https:\u002F\u002Fforpatients.roche.com\u002F No attachments to email below.","CONTACT","888-662-6728 (U.S. and Canada)","global-roche-genentech-trials@gene.com",{"name":31,"role":27,"phone":10,"phoneExt":10,"email":10},"Fastest response: use the inquiry form. https:\u002F\u002Fwww.gene.com\u002Fcontact-us\u002Fsubmit-medical-inquiry",[33,46,56,65,71,79,88,97,106,115,124,130,136,145,154,160,169,178,187],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":10},"Cancer Hospital Chinese Academy of Medical Sciences.","RECRUITING","Langfang","Hebei","065001","China",{"type":41,"coordinates":42},"Point",[43,44],116.71471,39.52079,{"lat":44,"lon":43},{"facility":47,"status":35,"city":48,"state":49,"zip":50,"country":39,"cosmosGeoPoint":51,"geoPoint":55,"contacts":10},"Chinese Academy of Medical Sciences Hematology Hospital;Lymphoma Diagnosis and Treatment Center","Tianjin","Tianjin Municipality","301636",{"type":41,"coordinates":52},[53,54],117.17667,39.14222,{"lat":54,"lon":53},{"facility":57,"status":35,"city":58,"state":10,"zip":59,"country":39,"cosmosGeoPoint":60,"geoPoint":64,"contacts":10},"Peking University People's Hospital","Beijing","100044",{"type":41,"coordinates":61},[62,63],116.39723,39.9075,{"lat":63,"lon":62},{"facility":66,"status":35,"city":58,"state":10,"zip":67,"country":39,"cosmosGeoPoint":68,"geoPoint":70,"contacts":10},"Peking University Third Hospital","100191",{"type":41,"coordinates":69},[62,63],{"lat":63,"lon":62},{"facility":72,"status":35,"city":73,"state":10,"zip":10,"country":39,"cosmosGeoPoint":74,"geoPoint":78,"contacts":10},"The First Bethune Hospital of Jilin University","Changchun",{"type":41,"coordinates":75},[76,77],125.32278,43.88,{"lat":77,"lon":76},{"facility":80,"status":35,"city":81,"state":10,"zip":82,"country":39,"cosmosGeoPoint":83,"geoPoint":87,"contacts":10},"West China Hospital of Sichuan University","Chengdu","610041",{"type":41,"coordinates":84},[85,86],104.06667,30.66667,{"lat":86,"lon":85},{"facility":89,"status":35,"city":90,"state":10,"zip":91,"country":39,"cosmosGeoPoint":92,"geoPoint":96,"contacts":10},"Guangdong Provincial People's Hospital","Guangzhou","510080",{"type":41,"coordinates":93},[94,95],113.25,23.11667,{"lat":95,"lon":94},{"facility":98,"status":35,"city":99,"state":10,"zip":100,"country":39,"cosmosGeoPoint":101,"geoPoint":105,"contacts":10},"Harbin Medical University Cancer Hospital","Harbin","150081",{"type":41,"coordinates":102},[103,104],126.65,45.75,{"lat":104,"lon":103},{"facility":107,"status":35,"city":108,"state":10,"zip":109,"country":39,"cosmosGeoPoint":110,"geoPoint":114,"contacts":10},"Shandong Cancer Hospital","Jinan","250117",{"type":41,"coordinates":111},[112,113],116.99722,36.66833,{"lat":113,"lon":112},{"facility":116,"status":35,"city":117,"state":10,"zip":118,"country":39,"cosmosGeoPoint":119,"geoPoint":123,"contacts":10},"Ruijin Hospital, Shanghai Jiaotong University School of Medicine","Shanghai","200025",{"type":41,"coordinates":120},[121,122],121.45806,31.22222,{"lat":122,"lon":121},{"facility":125,"status":35,"city":117,"state":10,"zip":126,"country":39,"cosmosGeoPoint":127,"geoPoint":129,"contacts":10},"Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","200233",{"type":41,"coordinates":128},[121,122],{"lat":122,"lon":121},{"facility":131,"status":35,"city":48,"state":10,"zip":132,"country":39,"cosmosGeoPoint":133,"geoPoint":135,"contacts":10},"Tianjin Cancer Hospital","300060",{"type":41,"coordinates":134},[53,54],{"lat":54,"lon":53},{"facility":137,"status":35,"city":138,"state":10,"zip":139,"country":39,"cosmosGeoPoint":140,"geoPoint":144,"contacts":10},"The First Affiliated Hospital of Wenzhou Medical University","Wenzhou","325035",{"type":41,"coordinates":141},[142,143],120.66682,27.99942,{"lat":143,"lon":142},{"facility":146,"status":35,"city":147,"state":10,"zip":148,"country":39,"cosmosGeoPoint":149,"geoPoint":153,"contacts":10},"Xiehe Hospital, Tongji Medical College Huazhong University of Science & Technology","Wuhan","430022",{"type":41,"coordinates":150},[151,152],114.26667,30.58333,{"lat":152,"lon":151},{"facility":155,"status":35,"city":147,"state":10,"zip":156,"country":39,"cosmosGeoPoint":157,"geoPoint":159,"contacts":10},"Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology","430030",{"type":41,"coordinates":158},[151,152],{"lat":152,"lon":151},{"facility":161,"status":35,"city":162,"state":10,"zip":163,"country":39,"cosmosGeoPoint":164,"geoPoint":168,"contacts":10},"The First Affiliated Hospital of Xian Jiao Tong University","Xi'an","710061",{"type":41,"coordinates":165},[166,167],108.92861,34.25833,{"lat":167,"lon":166},{"facility":170,"status":35,"city":171,"state":10,"zip":172,"country":39,"cosmosGeoPoint":173,"geoPoint":177,"contacts":10},"Yantai Yu Huangding Hospital","Yantai","264099",{"type":41,"coordinates":174},[175,176],121.44081,37.47649,{"lat":176,"lon":175},{"facility":179,"status":35,"city":180,"state":10,"zip":181,"country":39,"cosmosGeoPoint":182,"geoPoint":186,"contacts":10},"Henan Cancer Hospital","Zhengzhou","450008",{"type":41,"coordinates":183},[184,185],113.64861,34.75778,{"lat":185,"lon":184},{"facility":188,"status":35,"city":189,"state":10,"zip":10,"country":189,"cosmosGeoPoint":190,"geoPoint":194,"contacts":10},"Queen Mary Hospital","Hong Kong",{"type":41,"coordinates":191},[192,193],114.17469,22.27832,{"lat":193,"lon":192},{"type":196,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100608347",false,"NCT07200375","An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma","Evaluating Effectiveness and Safety of Glofitamab Based Second-Line Therapy in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter, Cohort Study","GlofitReal","Inclusion Criteria:\n\n* Histologically confirmed R\u002FR DLBCL after one line of systemic therapy\n* Will be treated with Glofit-based regimen (known as being recommended and having the intention to be treated with Glofitamab at the time of signing ICF) or have initiated Glofit-based regimen treatment within three months (90 days) prior to enrollment\n\nExclusion Criteria:\n\n* Participants who currently participate in or plan to participate in any interventional clinical trial","ALL","18 Years",{"count":207,"type":208},300,"ESTIMATED","OBSERVATIONAL","This study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R\u002FR DLBCL).",[212],"Diffuse Large B-Cell Lymphoma","2026-07-01",{"date":215,"type":216},"2026-07-02","ACTUAL",{"date":218,"type":216},"2025-09-29",{"date":220,"type":208},"2029-09-29",{"name":5,"class":6},19]